First Brain-Delivered Gene Therapy Approved for AADC Deficiency

(MedPage Today) -- The FDA granted accelerated approval to eladocagene exuparvovec (Kebilidi) to treat children and adults with aromatic L-amino acid decarboxylase (AADC) deficiency, the agency announced Thursday.
The treatment is the first approved...